VANCOUVER - InMed Pharmaceuticals Inc. (NASDAQ: INM), a small-cap biotech company with a market capitalization of $2.21 million, has announced the selection of an intravitreal (IVT) formulation, ...
A new formulation for medicine that does not need cold chain support, new air cargo friendly ultra-cold storage, and the FDA ...
This article is authored by Saransh Chaudhary, president, Global Critical Care, Venus Remedies Ltd and CEO, Venus Medicine ...
Scientists have developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method significantly enhances anti-tumor efficacy.
Award-winning Agility Life Sciences brings a proven track record in drug formulation for a number of pharmaceutical and biotechnology ...
INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the ...
Rheumatoid arthritis (RA) is an autoimmune disorder affecting millions worldwide, causing chronic inflammation, debilitating ...
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback